Concomitant type 2 diabetes mellitus (T2DM) in metastatic melanoma patients could be related to lower level of LAG-3: a transcriptomic analysis of a retrospective cohort

D. Mallardo; A. Cortellini; M. Capone; G. Madonna; David James PINATO; S. Warren; E. Simeone; P. A. Ascierto

doi:10.1016/j.annonc.2022.01.007

Concomitant type 2 diabetes mellitus (T2DM) in metastatic melanoma patients could be related to lower level of LAG-3: a transcriptomic analysis of a retrospective cohort

D. Mallardo
, A. Cortellini
, M. Capone
, G. Madonna
, David James PINATO
, S. Warren
, E. Simeone
, P. A. Ascierto

Department of Translational Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	445-447
Number of pages	3
Journal	Annals of Oncology
Volume	33
Issue number	4
DOIs	https://doi.org/10.1016/j.annonc.2022.01.007
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.annonc.2022.01.007

https://hdl.handle.net/11579/159454

Cite this

Mallardo, D., Cortellini, A., Capone, M., Madonna, G., PINATO, D. J., Warren, S., Simeone, E., & Ascierto, P. A. (2022). Concomitant type 2 diabetes mellitus (T2DM) in metastatic melanoma patients could be related to lower level of LAG-3: a transcriptomic analysis of a retrospective cohort. Annals of Oncology, 33(4), 445-447. https://doi.org/10.1016/j.annonc.2022.01.007

@article{403736f463414cdeb91a6f4f3de17b3c,

title = "Concomitant type 2 diabetes mellitus (T2DM) in metastatic melanoma patients could be related to lower level of LAG-3: a transcriptomic analysis of a retrospective cohort",

author = "D. Mallardo and A. Cortellini and M. Capone and G. Madonna and PINATO, \{David James\} and S. Warren and E. Simeone and Ascierto, \{P. A.\}",

year = "2022",

doi = "10.1016/j.annonc.2022.01.007",

language = "English",

volume = "33",

pages = "445--447",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "4",

}

Mallardo, D, Cortellini, A, Capone, M, Madonna, G, PINATO, DJ, Warren, S, Simeone, E & Ascierto, PA 2022, 'Concomitant type 2 diabetes mellitus (T2DM) in metastatic melanoma patients could be related to lower level of LAG-3: a transcriptomic analysis of a retrospective cohort', Annals of Oncology, vol. 33, no. 4, pp. 445-447. https://doi.org/10.1016/j.annonc.2022.01.007

TY - JOUR

T1 - Concomitant type 2 diabetes mellitus (T2DM) in metastatic melanoma patients could be related to lower level of LAG-3: a transcriptomic analysis of a retrospective cohort

AU - Mallardo, D.

AU - Cortellini, A.

AU - Capone, M.

AU - Madonna, G.

AU - PINATO, David James

AU - Warren, S.

AU - Simeone, E.

AU - Ascierto, P. A.

PY - 2022

Y1 - 2022

UR - https://iris.uniupo.it/handle/11579/159454

U2 - 10.1016/j.annonc.2022.01.007

DO - 10.1016/j.annonc.2022.01.007

M3 - Article

SN - 0923-7534

VL - 33

SP - 445

EP - 447

JO - Annals of Oncology

JF - Annals of Oncology

IS - 4

ER -

Concomitant type 2 diabetes mellitus (T2DM) in metastatic melanoma patients could be related to lower level of LAG-3: a transcriptomic analysis of a retrospective cohort

UN SDGs

Access to Document

Other files and links

Cite this